Response to "Questions arising on phlebotomy in polycythemia vera: prophylactic measures to reduce thromboembolic events require patient-focused decisions" by Heidel et al

Affiliations

• ¹ Center for the Study of Myelofibrosis, IRCCS Policlinico S. Matteo Foundation, Pavia, Italy. barosig@smatteo.pv.it.
• ² Department of Medicine and Surgery, University of Insubria, ASST Sette Laghi - Ospedale di Circolo, Varese, Italy.
• ³ Department of Hematology, Transfusion Medicine and Biotechnologies, Ospedale Civile, Pescara, Italy.
• ⁴ Dipartimento di Medicina Clinica e Chirurgia, Università di Napoli Federico II, Napoli, Italy.
• ⁵ Center for Research and Innovation of Myeloproliferative Neoplasms, AOU Careggi, and Laboratorio Congiunto, University of Florence, Florence, Italy.
• ⁶ Italian Society of Tranfusion Medicine and Immunohematology (SIMTI), Roma, Italy.
• ⁷ Department of Medicine, Haematology Research Centre, Division of Experimental Medicine, Imperial College London, London, UK.
• ⁸ University of Bologna, Bologna, Italy.
• ⁹ Clinical Research Foundation (FROM), Ospedale Papa Giovanni XXIII, Bergamo, Italy.